Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company“) today announced its financial results for the fourth quarter and fiscal year ended December 31, 2019. All amounts, unless specified...
Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company“) is pleased to announce that the holders (the “Noteholders“) of the subordinated secured convertible notes of the Company (the...
Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company“) is pleased to announce the receipt of the license amendment for Zenabis Langley Part 2A, representing an additional 39,400 kg...
Zenabis Global Inc (TSX: ZENA) (“Zenabis” or the “Company“) is pleased to announce that, further to its press release dated November 28, 2019 with respect to the completion of the Company’s...
Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company“) is pleased to provide an update on its recent facility construction and licensing activities and recent cannabis production results. Highlights:...
Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company“) is pleased to announce that it has closed its previously announced rights offering (the “Rights Offering“), which expired at 5:00 p.m. (EST) on November...
Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) continues investigating claims on behalf of investors who purchased shares of Sundial Growers Inc. (“Sundial” or the “Company”), a...